Opening book details…
About this Medicine article
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicentre, open-label phase-II trial by Cramer, Paula; v. Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; FÃ1⁄4rstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; DÃ1⁄4rig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Cramer, Paula; v. Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; FÃ1⁄4rstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; DÃ1⁄4rig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
- Publisher
- Ferrata Storti Foundation; Pavia: Fondazione Ferrata Storti; Ferrata Storti Foundation (Haematologica) (ISSN 0390-6078)
- Published
- 2020
- Field
- Medicine (Health Sciences)